
Haemonetics Corporation HAE
$ 59.26
-1.38%
Quarterly report 2025-Q4
added 02-05-2026
Haemonetics Corporation Operating Cycle 2011-2026 | HAE
Annual Operating Cycle Haemonetics Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 258 | 224 | 235 | 283 | 290 | 258 | 204 | 180 | 190 | 199 | 220 | 218 | 214 | 187 | 164 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 290 | 164 | 222 |
Quarterly Operating Cycle Haemonetics Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 274 | 297 | 314 | - | 274 | 273 | 251 | - | 222 | 228 | 226 | - | 212 | 223 | 272 | - | - | 305 | 150 | 55.6 | 285 | 281 | 315 | 305 | 235 | 222 | 214 | 203 | 172 | 171 | 175 | 58.2 | 178 | 189 | 200 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 315 | 55.6 | 226 |
Operating Cycle of other stocks in the Medical instruments industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Ekso Bionics Holdings
EKSO
|
495 | $ 11.79 | -1.83 % | $ 28.6 M | ||
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
37.1 | - | - | $ 1.75 B | ||
|
iRhythm Technologies
IRTC
|
67.6 | $ 120.8 | -6.47 % | $ 3.87 B | ||
|
Akers Biosciences, Inc.
AKER
|
184 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
197 | $ 74.09 | -1.04 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
129 | $ 4.07 | 2.01 % | $ 188 M | ||
|
Intuitive Surgical
ISRG
|
227 | $ 457.78 | 0.04 % | $ 163 B | ||
|
The Cooper Companies
COO
|
282 | $ 62.36 | -0.86 % | $ 12.4 B | ||
|
Antares Pharma, Inc.
ATRS
|
234 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
571 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Envista Holdings Corporation
NVST
|
132 | $ 26.33 | 1.5 % | $ 4.42 B | ||
|
Pulse Biosciences
PLSE
|
105 | $ 20.83 | -1.61 % | $ 1.4 B | ||
|
Masimo Corporation
MASI
|
168 | $ 178.48 | 0.03 % | $ 9.51 B | ||
|
Varian Medical Systems, Inc.
VAR
|
227 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
156 | $ 6.64 | 2.0 % | $ 56.3 K | ||
|
STAAR Surgical Company
STAA
|
100 | $ 27.19 | 3.15 % | $ 1.35 B | ||
|
STERIS plc
STE
|
144 | $ 214.4 | -1.14 % | $ 21.1 B | ||
|
ICU Medical
ICUI
|
185 | $ 118.85 | -0.29 % | $ 2.93 B | ||
|
Teleflex Incorporated
TFX
|
332 | $ 121.77 | -1.73 % | $ 5.43 B | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
237 | $ 140.22 | -2.7 % | $ 6.79 B | ||
|
InfuSystem Holdings
INFU
|
87.4 | $ 10.37 | 2.37 % | $ 214 M | ||
|
Microbot Medical
MBOT
|
180 | $ 2.1 | 0.48 % | $ 96.2 M | ||
|
Utah Medical Products
UTMD
|
339 | $ 65.77 | 0.54 % | $ 213 M | ||
|
Milestone Scientific
MLSS
|
533 | $ 0.34 | 9.03 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
198 | $ 62.01 | -9.05 % | $ 3.67 B | ||
|
West Pharmaceutical Services
WST
|
143 | $ 300.68 | 1.04 % | $ 21.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
120 | $ 11.81 | 0.51 % | $ 2.35 B | ||
|
Retractable Technologies
RVP
|
249 | $ 0.63 | 0.08 % | $ 18.9 M | ||
|
Pro-Dex
PDEX
|
228 | $ 48.36 | -3.55 % | $ 159 M | ||
|
LeMaitre Vascular
LMAT
|
42.9 | $ 112.04 | 2.09 % | $ 2.54 B | ||
|
Predictive Oncology
POAI
|
96.5 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
37.9 | $ 21.21 | 0.62 % | $ 977 M | ||
|
Stereotaxis
STXS
|
268 | $ 1.93 | 3.21 % | $ 176 M | ||
|
Baxter International
BAX
|
152 | $ 17.21 | -2.1 % | $ 8.83 B | ||
|
ResMed
RMD
|
202 | $ 205.02 | -4.11 % | $ 29.9 B | ||
|
AtriCure
ATRC
|
253 | $ 29.02 | 3.24 % | $ 1.39 B | ||
|
Harvard Bioscience
HBIO
|
285 | $ 6.36 | -0.31 % | $ 282 M | ||
|
NeuroMetrix
NURO
|
435 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
220 | $ 11.16 | 2.01 % | $ 456 M | ||
|
Becton, Dickinson and Company
BDX
|
169 | $ 149.31 | 0.13 % | $ 42.9 B | ||
|
Nephros
NEPH
|
212 | $ 3.11 | -1.58 % | $ 32.3 M | ||
|
OraSure Technologies
OSUR
|
251 | $ 2.95 | -2.96 % | $ 217 M | ||
|
Repligen Corporation
RGEN
|
297 | $ 117.2 | -0.94 % | $ 6.53 M |